2 weeks Ago By ABMN Staff
Progyny, Inc. ( NASDAQ:PGNY – Get Free Report ) has been given a consensus rating of “Hold” by the twelve analysts that are covering the firm, Marketbeat reports. Seven research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company.
The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $27.73. Several research firms recently issued reports on PGNY.
JPMorgan Chase & Co. cut their price target on shares of Progyny from $31.00 to $22.
00 and set an “overweight” rating on the stock in a report on Thursday, September 19th. Jefferies Financial Group reduced their price target on shares of Progyny from $31.00 to $24.
00 and set a “buy” rating on the stock in a research report on Thursday, September 19th. Canaccord Genuity Group downgraded Progyny from a “buy” rating to a “hold” rating and decreased their price target for the stock from $37.00 to $24.
00 in a research note on Wednesday, August 7th. Leerink Partnrs cut Progyny from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 7th. Finally, Canaccord Genuity Group decreased their target price on Progyny from $24.
00 to $18.00 and set a “hold” rating for the company in a research report on Friday, September 20th. Get Our Latest Stock Report on Progyny Progyny Price Performance Progyny ( NASDAQ:PGNY – Get Free Report ) last released its quarterly earnings results on Tuesday, August 6th.
The company reported $0.17 EPS for the quarter, hitting the consensus estimate of $0.17.
Progyny had a return on equity of 11.97% and a net margin of 5.54%.
The business had revenue of $304.09 million for the quarter, compared to analysts’ expectations of $305.32 million.
During the same quarter in the previous year, the firm posted $0.15 earnings per share. The company’s revenue was up 8.
8% compared to the same quarter last year. Analysts forecast that Progyny will post 0.64 earnings per share for the current fiscal year.
Insiders Place Their Bets In other news, President Michael E. Sturmer sold 9,030 shares of the company’s stock in a transaction dated Tuesday, July 16th. The shares were sold at an average price of $30.
00, for a total transaction of $270,900.00. Following the completion of the transaction, the president now owns 362,583 shares in the company, valued at $10,877,490.
The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink . 12.30% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On Progyny A number of institutional investors and hedge funds have recently added to or reduced their stakes in PGNY. Caprock Group LLC grew its stake in shares of Progyny by 5.3% in the first quarter.
Caprock Group LLC now owns 6,288 shares of the company’s stock worth $240,000 after purchasing an additional 319 shares in the last quarter. RiverPark Advisors LLC increased its stake in Progyny by 9.6% during the 2nd quarter.
RiverPark Advisors LLC now owns 5,408 shares of the company’s stock valued at $155,000 after buying an additional 474 shares during the period. State of Michigan Retirement System increased its stake in Progyny by 2.5% during the 1st quarter.
State of Michigan Retirement System now owns 20,479 shares of the company’s stock valued at $781,000 after buying an additional 500 shares during the period. Allspring Global Investments Holdings LLC raised its position in shares of Progyny by 9.5% during the 1st quarter.
Allspring Global Investments Holdings LLC now owns 6,260 shares of the company’s stock worth $239,000 after buying an additional 543 shares in the last quarter. Finally, Arizona State Retirement System lifted its stake in shares of Progyny by 2.6% in the 2nd quarter.
Arizona State Retirement System now owns 24,313 shares of the company’s stock worth $696,000 after acquiring an additional 609 shares during the period. 94.93% of the stock is owned by institutional investors.
About Progyny ( Get Free Report Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. Read More Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.
com's FREE daily email newsletter ..
